Clinical Trials Browser

Phase 2 × Recruiting × Stomatitis × Clear all

NCT06532279 2026-02-02

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Stomatitis

NCT06708702 2025-03-11

Copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy

Phase 2 Recruiting

40 enrolled

Stomatitis, Ulcer

NCT03581773 2025-03-05

DARENCA4

Phase 2 Recruiting

100 enrolled

Other

Stomatitis, Mucositis

NCT06354712 2025-01-15

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.

Phase 2 Recruiting

50 enrolled

Stomatitis, Ulcer

NCT05966194 2024-11-15

KEVLARx

Phase 2 Recruiting

216 enrolled

Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT06472739 2024-06-25

The Effect of GM-CSF to Preventing Oral Mucositis for Patients With Nasopharyngeal Carcinoma Receiving Radiotherapy

Phase 2 Recruiting

138 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Stomatitis